Naamit Sher

No open positions remaining

71 year

Health Technology

Consumer Services

Profile

Naamit Sher worked as the VP of Drug Development & Regulatory Affairs at Vascular Biogenics Ltd. She was also the Director of Quality Control & Quality Assurance at Interpharm Laboratories Ltd. and the Head of QC Laboratories at Teva Pharmaceutical Industries Ltd. Additionally, she held the title of Principal at Teva North America.
Dr. Sher received her undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.

Former positions of Naamit Sher

Companies	Position	End
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Corporate Officer/Principal	01/01/2006
Teva North America	Corporate Officer/Principal	-
Interpharm Laboratories Ltd. Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases	Corporate Officer/Principal	-
NOTABLE LABS, LTD.	General Counsel	-

See the detail of Naamit Sher's experience

Training of Naamit Sher

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Naamit Sher's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients	Health Technology
The Hebrew University of Jerusalem The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Teva North America
Interpharm Laboratories Ltd. Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases	Health Technology
Vascular Biogenics Ltd. Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer	Health Technology

See company connections